跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Risperdal - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Risperdal
Approved
STANDARD
Risperdal
Janssen Cilag SpA
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
22e6213fe4c1e6fa
Company
Janssen Cilag SpA
Type
Standard
Approval Details
Approval Id
22e6213fe4c1e6fa
Drug Approval Philippines Name
Risperdal
Product Name
Risperdal
Registration Number
DR-XY40690
Brand Name
Risperdal
Generic Name
Risperidone
Dosage Form
Tablet
Dosage Strength
2 mg
Manufacturer
Janssen Cilag SpA
Importer
Johnson & Johnson (Phils.) Inc.
Distributor
Zuellig Pharma Corporation
Company Detail Path
/organization/janssen-cilag-spa-milano-italy
Issuance Date
28 February 2022
Expiry Date
27 February 2027
Pharmacologic Category
Antipsychotic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
22e6213fe4c1e6fa
Type
Standard
Back to Philippines FDA Approvals